What is LOPJLB’s current signal on BEAM?

LOPJLB’s latest quantitative signal on Beam Therapeutics Inc. (BEAM) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is BEAM in?

Beam Therapeutics Inc. (BEAM) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Beam Therapeutics Inc. (BEAM) do?

Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell…

Where is Beam Therapeutics Inc. based / listed?

Beam Therapeutics Inc. is based in US, listed on NASDAQ.

Beam Therapeutics Inc. (BEAM)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$24.60-0.69%Close

SELLRECOVERY · day 4

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $2.5B
Beta: 2.20
P/E (TTM): -30.77

Short % float: 27.78%
Days to cover: 12.6
SI change: +0.3%

1W: +0.86%
1M: -2.30%

vs SPY 1W: -0.70%
vs SPY 1M: -4.07%

Industry peers

FMP comparable companies · ranked by market cap

CRSPSELLCRISPR Therapeutics AG$4.9BCRISISQ 20$50.44-3.65%
NTLABUYIntellia Therapeutics, Inc.$1.8BRECOVERYQ 3$12.60+7.60%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news